BofA Securities Upgrades Rocket Pharmaceuticals (RCKT) to Buy, 'Lift removes key uncertainty, setting up path to re-rating'
Tweet Send to a Friend
(Updated - August 20, 2025 1:58 PM EDT)
BofA Securities analyst Jason Zemansky upgraded Rocket Pharmaceuticals (NASDAQ: RCKT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Jason Zemansky upgraded Rocket Pharmaceuticals (NASDAQ: RCKT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
